| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 129.14B | 107.41B | 83.93B | 94.96B | 93.17B |
| Gross Profit | 47.97B | 36.35B | 23.67B | 26.76B | 28.18B |
| EBITDA | 36.17B | 24.27B | 13.94B | 17.75B | 19.77B |
| Net Income | 16.75B | 10.90B | 5.38B | 7.70B | 9.49B |
Balance Sheet | |||||
| Total Assets | 154.06B | 127.31B | 117.71B | 112.36B | 103.76B |
| Cash, Cash Equivalents and Short-Term Investments | 42.18B | 27.81B | 30.64B | 25.81B | 18.87B |
| Total Debt | 9.17B | 11.89B | 17.20B | 18.04B | 13.59B |
| Total Liabilities | 47.58B | 43.19B | 45.35B | 47.44B | 45.92B |
| Stockholders Equity | 80.10B | 62.90B | 56.60B | 50.95B | 45.58B |
Cash Flow | |||||
| Free Cash Flow | 26.51B | 6.83B | 9.46B | 7.11B | 3.36B |
| Operating Cash Flow | 28.60B | 8.86B | 11.88B | 8.30B | 6.30B |
| Investing Cash Flow | -7.53B | -3.33B | -3.19B | -1.28B | -3.01B |
| Financing Cash Flow | -10.48B | -7.45B | -6.11B | -379.00M | -3.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥277.98B | 8.85 | ― | 2.33% | 20.23% | 56.48% | |
81 Outperform | ¥863.60B | 10.13 | 9.10% | 1.63% | 9.80% | 13.15% | |
80 Outperform | ¥334.98B | 19.71 | ― | 1.17% | 29.22% | 29.50% | |
74 Outperform | ¥305.94B | 11.92 | 7.86% | 2.55% | 5.68% | 41.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥136.28B | 26.06 | 2.64% | 2.30% | 0.90% | 15.74% | |
58 Neutral | ¥460.40B | 55.37 | 11.46% | 3.77% | 2.76% | 56.11% |